Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

655
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
655
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

652
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
652
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

625
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
625
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

808
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
808
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

756
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
756
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Application-accompanying performance measurement for Digital Health Applications: Optimisation from a healthcare research perspective for targeted and healthcare-relevant performance measurement].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2026
Same author

Five years of the Digital Rheumatology Network: insights and future directions.

EULAR rheumatology open·2026
Same author

The role of perceived competence in remote cochlear implant aftercare: a mixed-methods study.

Frontiers in digital health·2026
Same author

Evaluating disease burden in German AAV patients using the AAV-PRO: associations with disease activity, physical function, depression, fatigue and quality of life.

Journal of patient-reported outcomes·2026
Same author

High Patient Willingness to Grant Broad Consent for Real-World Data Use in Rheumatology-Implications for Real-World Data Platform Governance: Cross-Sectional Study.

Journal of medical Internet research·2026
Same author

Low-energy small language models with retrieval-augmented generation can surpass large-model performance in rheumatology.

Frontiers in medicine·2026

Related Experiment Video

Updated: Apr 25, 2026

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
09:01

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Published on: June 5, 2010

13.4K

Thromboangiitis obliterans (Buerger's disease).

Peter F Klein-Weigel1, Jutta G Richter2

  • 1HELIOS Klinikum Berlin-Buch, Klinik für Angiologie, Berlin, Germany.

VASA. Zeitschrift Fur Gefasskrankheiten
|August 23, 2014
PubMed
Summary

Thromboangiitis obliterans (TAO), or Buerger's disease, is an inflammatory vascular condition linked to tobacco use. New therapies like stem cells and immunoadsorption offer hope for managing this disease causing limb ischemia.

Keywords:
Buerger`s diseaseThromboangiitis obliteransbosentancritical limb ischemiaimmunoadsorptionprogenitor cell therapystem cell therapyvasculitis

More Related Videos

Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
05:12

Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome

Published on: September 19, 2019

5.8K
A Rat Model of Tibial Cortex Transverse Transport for the Treatment of Lower Limb Ischemia
09:56

A Rat Model of Tibial Cortex Transverse Transport for the Treatment of Lower Limb Ischemia

Published on: March 6, 2026

601

Related Experiment Videos

Last Updated: Apr 25, 2026

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach
09:01

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Published on: June 5, 2010

13.4K
Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
05:12

Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome

Published on: September 19, 2019

5.8K
A Rat Model of Tibial Cortex Transverse Transport for the Treatment of Lower Limb Ischemia
09:56

A Rat Model of Tibial Cortex Transverse Transport for the Treatment of Lower Limb Ischemia

Published on: March 6, 2026

601

Area of Science:

  • Vascular Medicine
  • Immunology
  • Rheumatology

Background:

  • Thromboangiitis obliterans (TAO), also known as Buerger's disease, is an inflammatory vascular condition affecting small and medium-sized arteries and veins.
  • It is characterized by segmental thrombotic occlusions with mononuclear cellular thrombi and is strongly associated with tobacco use.
  • Emerging evidence suggests an immunopathogenesis, supported by immunohistological findings and autoantibody detection.

Purpose of the Study:

  • To summarize the key characteristics, clinical presentations, and diagnostic criteria for TAO.
  • To review current therapeutic strategies for Buerger's disease.
  • To highlight novel and emerging treatment options for TAO.

Main Methods:

  • Review of existing literature on Thromboangiitis obliterans.
  • Analysis of clinical features and diagnostic markers.
  • Evaluation of current and novel therapeutic approaches.

Main Results:

  • TAO presents clinically with distal ischemia syndromes, particularly in young individuals, often leading to high amputation rates.
  • The immunopathogenesis of TAO is increasingly recognized, involving immune system dysregulation.
  • New therapeutic avenues include stem cell-derived therapies, immunoadsorption, and the use of bosentan.

Conclusions:

  • Understanding the immunopathogenesis of TAO is crucial for effective management.
  • Early diagnosis and intervention are vital to prevent severe outcomes like amputation.
  • Novel therapies hold promise for improving treatment outcomes in patients with Buerger's disease.